Curaleaf International

We’re seeking a Supply Chain Manager to drive our end-to-end operations and strategy in Alcochete, Portugal 🇵🇹 This is a hands-on leadership role focused on operational excellence: ✅ Defining and executing Supply Chain strategy and KPIs. ✅ Leading production planning, warehouse, and logistics operations. ✅Championing cross-functional collaboration and continuous improvement. We're looking for: ➡️ A strategic, analytical leader with relevant experience. ➡️ Degree in Supply Chain, Logistics, or Engineering. ➡️ Proficiency with ERP systems and advanced Excel/analytics. Join us and help shape the future of evidence based cannabis. We offer fantastic benefits and real development opportunities in a rapidly growing organisation. 🌱 Apply today : https://lnkd.in/eU3Mgi83 #SupplyChainJobs #OperationsManager #CannabisIndustry #CuraleafInternational

We’ve joined the Universitat d'Alacant science park. Our Curaleaf team in Spain have officially joined the innovation hub, Deyaa AbuSalim, Ph.D., General Manager of Curaleaf International in Spain, shared: “From our base in the Alicante Science Park, we are boosting our research, development and innovation capacity, expanding our facilities and hiring the best scientific talent.” With one of the few Spanish licenses for medicinal cannabis research, Curaleaf continues to drive excellence across its global supply chain, from cultivation to distribution. As seen in the press: https://lnkd.in/e2C9H5K8

Our success is built on the tireless efforts of our exceptional teams. We recognise that 1 in 6 employees will experience a mental health challenge annually - a statistic none of us are exempt from. We are committed to fostering a supportive environment that prioritises the overall well-being of our people. To mark World Mental Health Day, we are reinforcing this commitment by raising awareness and highlighting key resources available across our international teams: ✅ Dedicated Support: We actively promote our Employee Assistance Programme (EAP), our comprehensive Well-being Policy, and our special Well-being Day benefit. ✅ Skill Building: We have partnered with Mental Health First Aid @MHFAEngland to equip our teams with the skills to support one another, including a network of trained Mental Health First Aiders across our HR and UK teams. We believe in the power of conversation and the importance of supporting those around us. By talking openly and building awareness, we help support each other. #WorldMentalHealthDay2025 #OneCuraleaf #MedicalCannabis

Happy International Happiness at Work Week! It’s easy to focus on the big deliverables, but true job satisfaction often comes from the little things: a collaborative brainstorm, a genuine "thank you", every day positive connections. This week, let's take a moment to actively appreciate what brings us joy and purpose in our work. Scroll to hear from some of our colleagues on what makes them happy at Curaleaf 👉🏽 #InternationalHappinessatWorkWeek #worklifeweek #OneCuraleaf

New preclinical research explores the mechanisms behind CBD's potential in animal models of addiction 🌱 A recent study in Biological Psychiatry investigated how cannabidiol (CBD) from cannabis may affect heroin seeking behaviour in rats. Key findings in this animal model: ➡️ CBD was shown to reduce cue-induced heroin seeking in rats following abstinence. ➡️ The analysis suggested that CBD modulated gene networks in the brain's Nucleus Accumbens Shell, an area associated with drug seeking. This is an important step forward in understanding the neurobiological pathways that CBD could potentially influence in the context of addiction research. While more research is needed, especially in human trials - this study lays the groundwork for further exploration in the setting of addiction 🔗 Read the full summary by Dr Simon Erridge: https://lnkd.in/epiYAByN

The Annual Pharmaceutical Industry Meeting (Reunião Anual do Colégio de Indústria, RACI) demonstrated the value and influence of pharmacists in assuring innovative, sustainable and quality medication, focused on people's health. Rita Carneiro, our Head of Quality across both our facilities in Portugal, presented on a panel exploring 'Hidden Frontlines of Pharmaceutical Practice', specifically on, 'Behind the Green: Medicinal Cannabis', and sharing powerful insights to the industry. Ordem dos Farmacêuticos #RACI2025

A small but meaningful step forward for patients in Spain 🇪🇸 Today, the Spanish Council of Ministers approved a long-awaited Royal Decree regulating the medicinal use of cannabis in standardised preparations. It’s encouraging to see progress toward a framework that recognises the therapeutic potential of cannabis when other medicines have been insufficient— and to see an emphasis on evidence-based prescribing and pharmaceutical quality. However, while this marks a positive shift, access remains highly limited: prescriptions can only be made by hospital-based specialists, and products must be prepared and dispensed exclusively in hospital pharmacies. We hope to see future evolutions of the current regulatory framework, where patient access to medical cannabis is eased and additional pharmaceutical forms are incorporated into the pool of available therapeutic tools for doctors. Read more: https://lnkd.in/dMZuVQmr #MedicalCannabis #Spain #PatientAccess #PolicyReform #EvidenceBasedMedicine

The Annual Meeting of the Order of Pharmacists (RACI) is happening October 3rd to 5th in Portugal 🇵🇹 We're thrilled that Curaleaf International will be represented by Rita Carneiro, our Head of Quality and Qualified Person, across both our facilities in Portugal. If you are there, make sure to catch Rita tomorrow, October 4th, speaking on the 'Hidden Frontlines of Pharmaceutical Practice' panel. Her expertise in quality assurance is crucial to advancing standards in our sector, and we know she'll bring invaluable insights to this important discussion. Ordem dos Farmacêuticos #CuraleafInternational #PharmaceuticalIndustry #RACI2025

How do caffeine and CBD change the effects of THC? ☕🌱 With cannabinoid containing food products on the rise, the combination of THC, CBD, and caffeine is becoming common, but the interaction effects remain largely unclear. A new randomised controlled trial published in Neuropsychopharmacology explored the effects of combining oral THC with caffeine and/or CBD in healthy adults. The key findings 🌱 ➡️ Caffeine had minimal impact on THC’s effects, including the “euphoria perceived driving impairment, or metabolism. ➡️ CBD, however, significantly altered THC’s effects - increasing both subjective euphoria and impairment on psychomotor tasks. ➡️ CBD also increased blood concentrations of THC, potentially boosting its potency when taken together. This is the first human study to directly assess how THC, CBD, and caffeine interact when consumed orally, highlighting the importance of understanding the entire cannabinoid profile in commercial products. This, however, is just one study considering only a single dose of THC, CBD, and caffeine respectively. More research is needed to fully understand the implications across a range of doses of all three compounds. Yet, this study does raise important considerations for both consumers and regulators navigating the rapidly evolving cannabis product market. Read the full summary by Dr Simon Erridge here: https://lnkd.in/g9HeeXMi

Last week #PTMC2025 in Lisbon, brought the global medical cannabis community together to share knowledge, challenges, and opportunities.  The event opened with Laura Ramos, and her insight set the stage for subsequent roundtable discussion. Key themes were consistent throughout: integrity, credibility, quality, compliance, and consideration for the complexity of cannabis. Highlights included the first panel with industry innovators, including Danielle Andrea (Curaleaf International). Helena Correia, Amit Edri, Fátima Godinho Carvalho and moderated by Sarah Sinclair Alongside the expert panellists, Danny spoke about the responsibility to patients, from ensuring access to delivering quality products. The panel explored pharmaceutical rigour, and the importance of safe and effective frameworks for achieving clinical validation. Other panels dived deep into cultivation, supply chain, best practices, and industry challenges, making it clear this is an exciting time to be part of the growing industry. A big thank you to CannaReporter® and the #PTMC team for hosting such a valuable conference. We’re proud to have been a sponsor and to connect with leading experts helping to shape the future of the sector. #MedicalCannabis #PTMC2025 #Portugal #HealthcareInnovation Rita Gonzalez caneiro Kirsty Martin